The effect of topical diclofenac 3% and calcitriol 3 μg/g on superficial basal cell carcinoma (sBCC) and nodular basal cell carcinoma (nBCC): A phase II, randomized controlled trial. [electronic resource]
Producer: 20170412Description: 126-34 p. digitalISSN:- 1097-6787
- Administration, Topical
- Aged
- Anti-Inflammatory Agents, Non-Steroidal -- administration & dosage
- Apoptosis -- drug effects
- Calcitriol -- administration & dosage
- Carcinoma, Basal Cell -- chemistry
- Cell Proliferation -- drug effects
- Diclofenac -- administration & dosage
- Drug Therapy, Combination
- Female
- Gels
- Humans
- Ki-67 Antigen -- analysis
- Male
- Medication Adherence
- Middle Aged
- Ointments
- Proto-Oncogene Proteins c-bcl-2 -- analysis
- Single-Blind Method
- Skin Neoplasms -- chemistry
- Treatment Outcome
- Vitamins -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.